跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NESINA MET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NESINA MET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack
Approved
STANDARD
NESINA MET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a8b00a8640942f6c
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
a8b00a8640942f6c
Product Name
NESINA MET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack
Artg Id
202309
Artg Name
NESINA MET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2013-10-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1099e328414e0ec195ebaa63c048357b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/20fd36c9e0cf60ae3894f72c6260257a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a8b00a8640942f6c
Type
Standard
Back to TGA Approvals